Alpha Zero’s Thermo Fisher Scientific TMO Stock Holding History

Alpha Zero’s Portfolio TMO Stock Details TMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-443	Closed	-$220K	–	65
2025 Q1	$220K	Sell	443 -12	-3%	-$6.5K	0.17%	57
2024 Q4	$237K	Buy	+455	New	+$250K	0.18%	64

Other funds holding TMO

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Alpha Zero's TMO Position: Q2 2025 in Review

Alpha Zero sold out of Thermo Fisher Scientific (TMO) in Q2 2025, closing a stake of 443 shares — an estimated $220K sold.

Alpha Zero first reported a position in TMO in Q4 2024 and held it in 2 quarters. The position peaked at $237K in Q4 2024. 2,458 funds tracked by Wall St. Rank hold TMO as of Q2 2025.

Alpha Zero reported no remaining Thermo Fisher Scientific position as of Q2 2025 after selling out during the quarter.
Alpha Zero sold 443 Thermo Fisher Scientific shares in Q2 2025, an estimated $220K.
Alpha Zero first reported a position in Thermo Fisher Scientific in Q4 2024 and held it in 2 quarters.
Alpha Zero's Thermo Fisher Scientific position peaked at $237K in Q4 2024.
2,458 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2025.

Based on Alpha Zero's 13F filing for Q2 2025, filed 12 Nov 2025.